Summary: This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
Trial Type: Treatment
Biological Sex: Male
Age Range: 18 Years and older
Cancer Type: Genitourinary
Phase: Phase 3
Study Sites:
The Cancer Center of Hawaii
Hawaii Cancer Care Inc.
The Queens Medical Center
